Assistance Listing 93.399
Cancer Control
National Institutes of Health · Department of Health and Human Services
The verdict for a small nonprofit
A realistic target for an established nonprofit. 47% of awards go to first-time applicants and nonprofits win 21%.
Based on 17 new awards in FY2023–25. The median award is $4,984,335. Expect about 238 days between posting and deadline.
- First-time winners
- 47%
- of new awards, last 3 FYs
- Nonprofit share
- 21%
- 68% higher ed · 0% gov't
- Under-$1M orgs
- n/a
- revenue join unavailable
- Median award
- $5.0M
- $5.0M – $5.0M middle half
- New awards, FY2025
- 1
- $5.0M committed to them
- Usually posts
- Nov
- rolling · 238-day window
Open right now under this program
40 opportunities · from Grants.gov, checked every 10 minutes
Who won in FY2025
Largest recipients by dollars. From USAspending.
| Recipient | Type | State | Awards | Awarded |
|---|---|---|---|---|
| Fred Hutchinson Cancer Center | Nonprofit | WA | 3 | $17,581,040 |
| University of Wisconsin System | Higher ed | WI | 2 | $12,379,232 |
| Northwestern University | Higher ed | IL | 2 | $8,456,218 |
| Baylor College of Medicine | Higher ed | TX | 2 | $8,109,849 |
| Sloan-Kettering Institute for Cancer Research | Nonprofit | NY | 2 | $7,178,670 |
| Virginia Commonwealth University | Higher ed | VA | 2 | $6,779,349 |
| University of North Carolina at Chapel Hill | Higher ed | NC | 2 | $6,409,634 |
| University of Washington | Higher ed | WA | 2 | $5,716,463 |
| Emory University | Higher ed | GA | 2 | $2,570,724 |
| The Institute for Cancer Research | Nonprofit | PA | 1 | $6,753,989 |
New awards by fiscal year
Awards first made in each fiscal year; dollars are the total committed to that year's new awards over their life.
| FY | New awards | Committed | Median | Middle half |
|---|---|---|---|---|
| 2021 | 9 | $32M | $3.2M | $3.0M – $3.4M |
| 2022 | 12 | $52M | $4.3M | $2.6M – $6.1M |
| 2023 | 7 | $12M | $1.3M | $948K – $1.4M |
| 2024 | 9 | $30M | $3.6M | $3.2M – $3.7M |
| 2025 | 1 | $5.0M | $5.0M | $5.0M – $5.0M |
Past rounds
Every announcement under this listing that Grants.gov still lists. Use it to plan next year.
| Posted | Closed | Window | Announcement |
|---|---|---|---|
| 2026-10-14 | 2029-05-25 | 954 d | PA-27-061 · NIH Research Program Projects (Parent P01 Clinical Trial Optional) |
| 2026-10-09 | 2027-02-09 | 123 d | RFA-CA-28-013 · Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) |
| 2026-10-06 | 2029-06-20 | 988 d | RFA-AI-27-018 · Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) |
| 2026-09-01 | 2029-04-17 | 959 d | PAR-27-051 · NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) |
| 2026-08-31 | 2027-01-25 | 147 d | PAR-28-062 · Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) |
| 2026-07-30 | forecast | — | PAR-28-037 · Investigator-Focused Award (Parent R35) |
| 2026-07-28 | forecast | — | RFA-CA-28-003 · Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
| 2026-06-08 | 2026-07-09 | 31 d | RFA-DA-27-003 · Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study Renewal - Data Analysis, Informatics and Resource Center, and Coordinating Center (U24 Clinical Trial Not Allowed) |
| 2026-06-08 | 2026-07-09 | 31 d | RFA-DA-27-002 · Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study-Research Project Sites (U01 Clinical Trial Not Allowed) |
| 2026-05-29 | 2027-10-25 | 514 d | PAR-27-078 · Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
| 2026-05-21 | 2026-10-19 | 151 d | RFA-CA-27-020 · Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
| 2026-05-21 | 2027-10-19 | 516 d | RFA-CA-27-019 · Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
| 2026-05-21 | 2026-09-18 | 120 d | RFA-CA-27-006 · NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) |
| 2026-05-21 | 2026-09-18 | 120 d | RFA-CA-27-008 · NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed) |
| 2026-05-21 | 2026-09-18 | 120 d | RFA-CA-27-007 · NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) |
| 2026-05-21 | 2026-10-19 | 151 d | RFA-CA-27-021 · Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
| 2026-05-06 | forecast | — | PAR-27-089 · NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) |
| 2026-05-06 | forecast | — | PAR-27-088 · NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) |
| 2026-05-04 | 2029-07-05 | 1158 d | PAR-27-072 · Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
| 2026-01-20 | 2029-05-07 | 1203 d | PA-26-002 · NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) |
| 2025-12-02 | 2026-02-12 | 72 d | RFA-CA-25-032 · Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) |
| 2025-11-26 | 2028-11-30 | 1100 d | PA-26-001 · Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
| 2025-06-18 | — | — | NOT-CA-25-104 · Forecast to Publish a Funding Opportunity Announcement for the Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) |
| 2025-06-16 | forecast | — | FOR-CA-25-077 · Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) |
| 2025-06-11 | — | — | PAR-27-120 · Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
| 2025-05-27 | forecast | — | RFA-AI-28-025 · Implementation and Evaluation of Databases to Examine AIDS |
| 2025-01-22 | 2027-01-07 | 715 d | PAR-25-379 · Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) |
| 2025-01-13 | 2026-11-16 | 672 d | PAR-25-370 · Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
| 2025-01-13 | 2026-11-18 | 674 d | PAR-25-371 · Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
| 2025-01-13 | 2026-11-18 | 674 d | PAR-25-369 · Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
| 2025-01-08 | 2025-02-24 | 47 d | RFA-NR-25-004 · Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) |
| 2025-01-08 | 2026-01-08 | 365 d | PAR-25-354 · Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
| 2025-01-08 | 2026-01-08 | 365 d | PAR-25-355 · Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
| 2025-01-06 | 2028-09-07 | 1340 d | PAR-25-324 · Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) |
| 2024-12-18 | 2028-01-07 | 1115 d | PA-25-306 · NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) |
| 2024-12-18 | 2028-01-07 | 1115 d | PA-25-301 · NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
| 2024-12-18 | 2026-05-24 | 522 d | PA-25-303 · NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
| 2024-12-18 | 2028-01-07 | 1115 d | PA-25-304 · NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) |
| 2024-12-16 | 2025-12-09 | 358 d | RFA-CA-25-019 · Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) |
| 2024-12-13 | 2027-03-06 | 813 d | PAR-25-317 · Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) |
Common questions
How hard is it to win a grant under 93.399?
A realistic target for an established nonprofit. 47% of awards go to first-time applicants and nonprofits win 21%. Based on 17 new awards in FY2023–25. The median award is $4,984,335. Expect about 238 days between posting and deadline.
How much does Cancer Control award?
In FY2025 the median new award was $5.0M; the middle half ran from $5.0M to $5.0M. 1 new awards were made, with $5.0M committed to them.
When does 93.399 usually post?
Over the last several years, new rounds most often posted in Nov with about 238 days to apply. The most recent round posted Oct 14, 2026.
Who runs this program?
Department of Health and Human Services (National Institutes of Health). Assistance Listing 93.399 on SAM.gov describes the authorizing statute and standard terms.
Sources: USAspending FY2021–25 award archive (2026-10-06); Grants.gov Search2 (fetched 2026-10-28); IRS EO BMF (fetched 2026-10-28). Award counts are new awards by fiscal year of first action. Shares are computed from award counts, not dollars; the under-$1M share covers the 67% of nonprofit awards that matched an IRS revenue record. Recipient type comes from the award record's business-type codes. Always confirm details in the official announcement.